Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas [Phase 1]

View source ↗

Summary

Phase 1 trial using magnetic resonance fingerprinting to guide extended surgical resection in patients with glioblastoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma, Brain Tumor | Phase 1 | Status: NOT_YET_RECRUITING